Imidazopyridines

US5532276A · kind A · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Werner Mederski · Zwingenberg, DE
• Dieter Dorsch · Ober-Ramstadt, DE
• Mathias Osswald · Zwingenberg, DE
• Norbert Beier · Reinheim, DE
• Pierre Schelling · Mühltal, DE
• Klaus-Otto Minck · Ober-Ramstadt, DE
• Ingeborg Lues · Darmstadt, DE

Key dates

• Filing date: Dec 5, 1994
• Grant date: Jul 2, 1996
• Expiry date: Dec 5, 2014

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Novel imidazopyridine derivatives of the formula ##STR1## wherein R is ##STR2## and R.sup.1, R.sup.2, R.sup.3, R.sup.4, Ar.sup.1, X and Y are as defined in the specification, and their salts, exhibit antagonistic properties toward angiotensin II and can be used for the treatment of hypertension, aldosteronism, cardiac insufficiency and increased intraocular pressure, and of disorders of the central nervous system.